To repeal the amendments made to the Controlled Substances Act by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.
Sponsored By: Representative Kuster, Ann M. [D-NH-2]
Unknown
Summary
This bill repeals two sections of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 and the amendments made by such sections to the Controlled Substances Act. The repealed sections modified registration and enforcement authorities of the Drug Enforcement Administration with respect to manufacturers, distributors, and dispensers of controlled substances.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Kuster, Ann M. [D-NH-2]
NH • D
Cosponsors
Rep. Doggett, Lloyd [D-TX-37]
TX • D
Sponsored 11/29/2017
Rep. Jenkins, Evan H. [R-WV-3]
WV • R
Sponsored 10/19/2017
Rep. Ryan, Tim [D-OH-13]
OH • D
Sponsored 10/19/2017
Rep. Cooper, Jim [D-TN-5]
TN • D
Sponsored 10/19/2017
Rep. Esty, Elizabeth H. [D-CT-5]
CT • D
Sponsored 11/29/2017
Rep. Cohen, Steve [D-TN-9]
TN • D
Sponsored 12/1/2017
Rep. DelBene, Suzan K. [D-WA-1]
WA • D
Sponsored 12/1/2017
Rep. Jackson Lee, Sheila [D-TX-18]
TX • D
Sponsored 12/1/2017
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov